MERCYONE ELKADER MEDICAL CENTER — History
CCN 161319 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$12M
Latest Revenue (FY2022)
+13.5%
Revenue CAGR (3yr)
0.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $10M | $10M | $12M | +26.2% | +13.5% |
| Operating Expenses | $9M | $10M | $12M | +16.8% | +14.2% |
| Operating Margin | 2.1% | -7.0% | 0.9% | +113.6% | -32.9% |
| Net Income | $0M | $-1M | $0M | +117.1% | -23.8% |
| Licensed Beds | 15 | 15 | 15 | +0.0% | +0.0% |
| Total Patient Days | 1,093 | 916 | 975 | +6.4% | -5.6% |
| Medicare Day % | 78% | 72% | 65% | -10.2% | -8.6% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +28.9% ($10M → $12M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+13.5%
This Hospital
+7.6%
State Avg
Latest Margin
0.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $14M | 0.4% |
| FY2024 (proj) | $15M | -0.2% |
| FY2025 (proj) | $16M | -0.8% |